Clinical trials
Observational trials in Senegal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 8 |
| Recruiting | 5 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| French Africa Pediatric Oncology Group | 5 |
| Cardiologie et Développement | 3 |
| ANRS, Emerging Infectious Diseases | 2 |
| Biomedical Research Center EPLS | 2 |
| Institut de Recherche pour le Developpement | 2 |
| Alliance For Medical Research in Africa | 1 |
| Association of Future African Neurosurgeons, Yaounde, Cameroon | 1 |
| Bernhard Nocht Institute for Tropical Medicine | 1 |
| Dissou AFFOLABI | 1 |
| Drugs for Neglected Diseases | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Anemia | 2 |
| Anemia, Sickle Cell | 2 |
| COVID-19 | 2 |
| Disease | 2 |
| Endocarditis | 2 |
| Malaria | 2 |
| Malnutrition | 2 |
| Neoplasms | 2 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.